Lista de obras -

A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation

artículo científico publicado en 2017

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.

artículo científico publicado en 2018

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

scientific article published on 19 August 2019

CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation

artículo científico publicado en 2015

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma

artículo científico publicado en 2019

Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial

scientific article published on 19 June 2019

Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life population

artículo científico publicado en 2019

Engineered nanomedicine for myeloma and bone microenvironment targeting.

artículo científico publicado en 2014

Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia.

artículo científico publicado en 2016

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

artículo científico publicado en 2017

Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia.

artículo científico publicado en 2013

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

scientific article published on 22 May 2020

Global epigenetic regulation of microRNAs in multiple myeloma

artículo científico publicado en 2014

IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.

artículo científico publicado en 2014

IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.

artículo científico publicado en 2016

Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis.

artículo científico

Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

artículo científico publicado en 2017

Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche

artículo científico publicado en 2018

Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.

artículo científico publicado en 2014

Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia

artículo científico publicado en 2012

Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice.

artículo científico publicado en 2017

Prognostic role of circulating exosomal miRNAs in multiple myeloma

artículo científico publicado en 2017

Prognostic value of PINI index in patients with multiple myeloma.

artículo científico publicado en 2012

Pyk2 promotes tumor progression in multiple myeloma

artículo científico publicado en 2014

Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström's macroglobulinemia.

artículo científico publicado en 2017

Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib

artículo científico publicado en 2014

Targeting the bone marrow microenvironment in multiple myeloma.

artículo científico publicado en 2015

The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma.

artículo científico publicado en 2017

The cancer glycome: carbohydrates as mediators of metastasis

artículo científico publicado en 2015

The role of miRNAs in plasma cell dyscrasias

scientific article published on 01 January 2014

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma

artículo científico publicado en 2014

Lista de obras de

A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation

A predictive model for risk of early grade ≥ 3 infection in patients with multiple myeloma not eligible for transplant: analysis of the FIRST trial.

A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial

CXCR4 Regulates Extra-Medullary Myeloma through Epithelial-Mesenchymal-Transition-like Transcriptional Activation

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma

Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial

Daratumumab is effective in the relapsed or refractory systemic light-chain amyloidosis but associated with high infection burden in a frail real-life population

Engineered nanomedicine for myeloma and bone microenvironment targeting.

Exome sequencing reveals recurrent germ line variants in patients with familial Waldenström macroglobulinemia.

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia.

Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression

Global epigenetic regulation of microRNAs in multiple myeloma

IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma.

IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia.

Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosis.

Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma.

Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche

Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model.

Mechanisms of activity of the TORC1 inhibitor everolimus in Waldenstrom macroglobulinemia

Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice.

Prognostic role of circulating exosomal miRNAs in multiple myeloma

Prognostic value of PINI index in patients with multiple myeloma.

Pyk2 promotes tumor progression in multiple myeloma

Role of IRF4 in resistance to immunomodulatory (IMid) compounds® in Waldenström's macroglobulinemia.

Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib

Targeting the bone marrow microenvironment in multiple myeloma.

The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma.

The cancer glycome: carbohydrates as mediators of metastasis

The role of miRNAs in plasma cell dyscrasias

The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma